Mike Mitka. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Anticholesteremic Agents/therapeutic useAzetidinesCardiovascular Diseases/epidemiologyCardiovascular Diseases/prevention & controlCarotid Arteries/diagnostic imagingCarotid Arteries/pathologyCholesterol, LDL/drug effectsClinical Trials as TopicDrug ApprovalEzetimibeHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHypercholesterolemia/drug therapyHypolipidemic Agents/administration & dosageNiacin/administration & dosagePractice Patterns, Physicians'/statistics & numerical dataRisk FactorsSimvastatin/therapeutic useTreatment OutcomeUltrasonographyUnited StatesUnited States Food and Drug Administration
Substances: See more » Anticholesteremic AgentsAzetidinesCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsNiacinSimvastatinEzetimibe
Year: 2010 PMID: 20085945 DOI: 10.1001/jama.2009.1915
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272